KOL KNOCKOUTTM: Oculoplastics Edition

KOL KNOCKOUT Oculoplastics Edition Sculpting Sight For Patients With Thyroid Eye Disease Round 2

Thank you for attending. The posttest will not be available immediately. You will receive an email with a link to obtain credit within 48 hours of the program's completion.

Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual activity until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

Scroll back to top

Details

Overview
Get ready for Round 2 of KOL KNOCKOUT™ in Oculoplastics with an all new lineup, including Drs. Kian Eftekhari, Andrew G. Lee, and Jeremiah Tao. Program Chair Dr. Andrew R. Harrison will officiate as these experts spar over complex cases of thyroid eye disease (TED) and its mimickers. You vote for the KOL that presents the best treatment strategy. The winner will advance to the live, in-person, final round at the Fall ASOPRS meeting in October. Get ready for a bout filled with clinical insights and expertise!
Note About Obtaining Credit:
You must attend the course in its entirety.
COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

This activity is supported by an unrestricted educational grant from Amgen.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Conduct comprehensive clinical assessments, including the appropriate use of laboratory tests and radiologic imaging, to recognize the heterogenous presentation of thyroid eye disease and ascertain potential thyroid dysfunction
- Propose medically relevant treatment regimens together with customized surgical approaches to address the physical burden and reduced quality of life due to thyroid eye disease
- Formulate effective comanagement strategies with relevant health care professionals to optimize treatment outcomes and manage adverse events
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 128874 is accredited by COPE for continuing education for optometrists. This course is approved for 1.0 hour of CE.
Course #: 92296-SD
Activity #: 128874
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Participation Method
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Faculty and Disclosures
Andrew R. Harrison, MD
Professor of Ophthalmology
and Otolaryngology
Director, Oculofacial Plastic
and Orbital Surgery
Vice Chair, Surgical Services and Quality
Co-director, Center for Thyroid Eye Disease
University of Minnesota
Minneapolis, MN

Kian Eftekhari, MD
Oculofacial Plastic and Reconstructive Surgeon
Eyelid Center of Utah
Salt Lake City, UT

Andrew G. Lee, MD
Herb and Jean Lyman Centennial Chair of Ophthalmology
Blanton Eye Institute
Houston Methodist Hospital
Houston, TX

Jeremiah Tao, MD, FACS
Professor of Ophthalmology
Chief, Oculofacial Plastic & Orbital Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Andrew R. Harrison, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Horizon Therapeutics, Lassen Therapeutics, RVL, and Viridian Therapeutics. Grant/Research Support: Viridian Therapeutics. Speaker's Bureau: Amgen, Horizon Therapeutics, and RVL.
Kian Eftekhari, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Grant/Research Support: Genentech and Sling Theapeutics.
Andrew G. Lee, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alexion, Amgen, AstraZeneca, Bristol Myers Squibb, Horizon Therapeutics, Stoke Therapeutics, Tshaka Bio, and Viridian Therapeutics. Speaker's Bureau: Alexion, Amgen, AstraZeneca, Bristol Myers Squibb, Horizon Therapeutics, Stoke Therapeutics, Tshaka Bio, and Viridian Therapeutics.
Jeremiah Tao, MD, FACS, has had no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Note About Obtaining Credit:
You must attend the course in its entirety.
COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 10/04/2024

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Title

Share on ReachMD